Illumina, General Atlantic and Viking Global have supplied $70m for Ginkgo Bioworks, an MIT spinout that has now raised more than $789m altogether.

Q32 Bio has launched with $46m from investors including University of Colorado to target autoimmune and inflammatory diseases.

Illumina, General Atlantic and Viking Global Investors supplied $70m for Ginkgo Bioworks, a cell programming technology provider that has now raised more than $789m altogether.

Amazon Alexa Fund contributed to the home automation technology producer's series C round through its Alexa Fund, revealing itself as an existing investor in the process.

Existing investors Hewlett Packard Enterprise, GV, Intel Capital, SingTel Innov8 and M12 all participated as the cybersecurity services provider took its total funding to $112m.

Existing backer Ligand took part in a series C round that will fund late-stage clinical trials for Palvella Therapeutics' rare genetic disease drug candidates.

Q32 Bio has launched with $46m from investors including Sanofi Ventures and Children’s Hospital Colorado to target autoimmune and inflammatory diseases.

BOCG Investment was among the participants in a round that will fund technology and strategic investments for the Haier-backed logistics service.

The call management platform developer has completed a series C round led by DTCP that also featured Swisscom Ventures.

EDP Ventures and Semapa Next took part in a $50.5m series B round for the AI verification data provider, which counts Amazon, Sony and Mastercard as earlier investors.